Showing results (701-710 of 1,516) with videos related to
Sort By:
Pageof 152
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 12, 2018
Design and conduct of early clinical studies of immunotherapy agent combinations: recommendations from the task force on Methodology for the Development of Innovative Cancer TherapiesM Smoragiewicz, J Bogaerts, E Calvo, et al.Nature Medicine|April 21, 2026
Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposureSilvana C E Maas, Iosune Baraibar, Lea Lemler, et al.Breast Cancer Research and Treatment|April 1, 1995
A phase III randomized trial of cyclophosphamide, mitoxantrone, and 5-fluorouracil (CNF) versus cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) in patients with metastatic breast cancerM C Alonso, J M Tabernero, B Ojeda, et al.Cancer|July 24, 2001
Gains of chromosome 22 by fluorescence in situ hybridization in the context of an hyperdiploid karyotype are associated with aggressive clinical features in meningioma patientsA Maíllo, P Díaz, J M Sayagués, et al.Nutricion Hospitalaria|February 27, 2004
[Chronic liver disease associated with cystic fibrosis: energy expenditure at rest, risk factors, and impact on the course of the disease]S Tabernero da Veiga, Y González Lama, R Lama More, et al.Antiviral Research|March 26, 2013
A comparative study of ultra-deep pyrosequencing and cloning to quantitatively analyze the viral quasispecies using hepatitis B virus infection as a modelClara Ramírez, Josep Gregori, Maria Buti, et al.Revista Espanola De Geriatria Y Gerontologia|January 27, 2016
[Non-invasive ventilation in 'do-not-intubate' patients in a chronic disease hospital. One year follow-up study]Eva Tabernero Huguet, Pilar Gil Alaña, Eunate Arana-Arri, et al.Gut|July 17, 2012
A combined oncogenic pathway signature of BRAF, KRAS and PI3KCA mutation improves colorectal cancer classification and cetuximab treatment predictionSun Tian, Iris Simon, Victor Moreno, et al.Frontiers in Public Health|November 9, 2023
Reporting reimbursement price decisions for onco-hematology drugs in SpainDavid Elvira, Ferran Torres, Roser Vives, et al.International Journal of Biological Macromolecules|September 19, 2024
Controlling particle size of levan in powder form with different technologiesStefania Mottola, Gianluca Viscusi, Álvaro González-Garcinuño, et al.Pageof 152